DK1069892T3 - Fugtighedsaktiverbart terapeutisk system - Google Patents

Fugtighedsaktiverbart terapeutisk system

Info

Publication number
DK1069892T3
DK1069892T3 DK99914523T DK99914523T DK1069892T3 DK 1069892 T3 DK1069892 T3 DK 1069892T3 DK 99914523 T DK99914523 T DK 99914523T DK 99914523 T DK99914523 T DK 99914523T DK 1069892 T3 DK1069892 T3 DK 1069892T3
Authority
DK
Denmark
Prior art keywords
skin
mucous membrane
active agent
activating agent
therapeutic system
Prior art date
Application number
DK99914523T
Other languages
English (en)
Inventor
Stefan Bracht
Original Assignee
Lohmann Therapie Syst Lts
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lohmann Therapie Syst Lts filed Critical Lohmann Therapie Syst Lts
Application granted granted Critical
Publication of DK1069892T3 publication Critical patent/DK1069892T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
    • A61M31/002—Devices for releasing a drug at a continuous and controlled rate for a prolonged period of time
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Anesthesiology (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK99914523T 1998-03-30 1999-03-18 Fugtighedsaktiverbart terapeutisk system DK1069892T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19814087A DE19814087A1 (de) 1998-03-30 1998-03-30 Feuchtigkeitsaktivierbares therapeutisches System
PCT/EP1999/001802 WO1999049853A1 (de) 1998-03-30 1999-03-18 Feuchtigkeitsaktivierbares therapeutisches system

Publications (1)

Publication Number Publication Date
DK1069892T3 true DK1069892T3 (da) 2002-12-02

Family

ID=7862905

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99914523T DK1069892T3 (da) 1998-03-30 1999-03-18 Fugtighedsaktiverbart terapeutisk system

Country Status (13)

Country Link
US (1) US7175853B1 (da)
EP (1) EP1069892B1 (da)
JP (1) JP4252212B2 (da)
KR (1) KR100550886B1 (da)
AT (1) ATE221774T1 (da)
AU (1) AU3331299A (da)
CA (1) CA2326662C (da)
DE (2) DE19814087A1 (da)
DK (1) DK1069892T3 (da)
ES (1) ES2182507T3 (da)
NO (1) NO20004835D0 (da)
PT (1) PT1069892E (da)
WO (1) WO1999049853A1 (da)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10053397A1 (de) 2000-10-20 2002-05-02 Schering Ag Verwendung eines dopaminergen Wirkstoffes zur Behandlung von dopaminerg behandelbaren Erkrankungen
DE10137162A1 (de) * 2001-07-30 2003-02-20 Hexal Ag Matrixkontrolliertes transdermales therapeutisches System zur Anwendung von Pramiprexol und Ropinirol
DE10159745A1 (de) 2001-12-05 2003-07-03 Lohmann Therapie Syst Lts Transdermales Therapeutisches System mit verbessertem Langzeittragekomfort
DE102007041734A1 (de) * 2006-12-20 2008-06-26 Tesa Ag Repulpierbare Klebmassen
US9155725B2 (en) 2008-02-27 2015-10-13 Hisamitsu Pharmaceutical Co., Inc. Adhesive skin patch and packaged product
ES2648197T3 (es) 2008-02-27 2017-12-29 Hisamitsu Pharmaceutical Co., Inc. Parche medicado
DE102008013701A1 (de) * 2008-03-11 2009-09-17 Lts Lohmann Therapie-Systeme Ag Transdermales Therapeutisches System mit stabilisierter Membran
ES2589008T3 (es) * 2009-04-24 2016-11-08 Hisamitsu Pharmaceutical Co., Inc. Bolsa de envase que contiene parche adhesivo y método para almacenar parche adhesivo
US9238025B2 (en) * 2009-05-21 2016-01-19 Hisamitsu Pharmaceutical Co., Inc. Transdermal preparation comprising a ropinirole derivative
DE102009022915A1 (de) * 2009-05-27 2010-12-09 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System mit gesteuertem Wirkstofffluss
CN102781473B (zh) * 2009-11-12 2016-02-17 学校法人日本大学 外用药物组合物
DK2515886T3 (da) * 2009-12-22 2018-06-14 Luye Pharma Ag Transdermalt terapeutisk system til indgivelse af rivastigmin eller derivater deraf
US10076502B2 (en) 2009-12-22 2018-09-18 Luye Pharma Ag Transdermal therapeutic system for administering rivastigmine or derivatives thereof
MA33904B1 (fr) * 2010-01-14 2013-01-02 Novartis Ag Utilisation d'un agent de modification d'hormones surrénaliennes
CN108186611A (zh) 2010-04-30 2018-06-22 帝国制药美国公司 丙炔基氨基茚满透皮组合物
DE102010024105A1 (de) * 2010-06-17 2011-12-22 Grünenthal GmbH Transdermale Verabreichung von Memantin
WO2012129429A2 (en) 2011-03-24 2012-09-27 Teikoku Pharma Usa, Inc. Transdermal compositions comprising an active agent layer and an active agent conversion layer
CN103561737A (zh) * 2011-05-31 2014-02-05 久光制药株式会社 含有罗匹尼罗的贴附剂及其包装体
WO2013070526A1 (en) 2011-11-09 2013-05-16 Teikoku Pharma Usa, Inc. Methods for the treatment of skin neoplasms
US9481777B2 (en) 2012-03-30 2016-11-01 The Procter & Gamble Company Method of dewatering in a continuous high internal phase emulsion foam forming process
US9205061B2 (en) 2012-11-02 2015-12-08 Teikoku Pharma Usa, Inc. Propynylaminoindan transdermal compositions
WO2015137872A1 (en) * 2014-03-13 2015-09-17 Innovator Skåne Ab Tubular or sheet-shaped drug delivery system
CN110475548A (zh) * 2016-12-29 2019-11-19 纯比率控股股份有限公司 模块化透皮递送系统以及相关制备和使用方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0249343B1 (en) * 1986-06-13 1992-01-08 Alza Corporation Moisture activation of transdermal drug delivery system
US4781924A (en) * 1987-11-09 1988-11-01 Alza Corporation Transdermal drug delivery device
US4837027A (en) * 1987-11-09 1989-06-06 Alza Corporation Transdermal drug delivery device
AT392587B (de) * 1988-03-03 1991-04-25 Sandoz Ag Pharmazeutische zusammensetzung enthaltend phenylcarbamate
DE3905050A1 (de) 1989-02-18 1990-08-30 Lohmann Therapie Syst Lts Therapeutisches system zur verzoegerten und gesteuerten transdermalen oder transmucosalen verabreichung von wirkstoffen (ii)
DE3905051A1 (de) * 1989-02-18 1990-08-30 Lohmann Therapie Syst Lts Therapeutisches system zur verzoegerten und gesteuerten transdermalen oder transmucosalen verabreichung von wirkstoffen (i)
DE3910543A1 (de) 1989-04-01 1990-10-11 Lohmann Therapie Syst Lts Transdermales therapeutisches system mit erhoehtem wirkstofffluss und verfahren zu seiner herstellung
JPH04124128A (ja) * 1990-09-13 1992-04-24 Lion Corp 肛門部疾患治療用貼付剤
US5989586A (en) 1992-10-05 1999-11-23 Cygnus, Inc. Two-phase matrix for sustained release drug delivery device
GB2290964A (en) * 1994-07-08 1996-01-17 Arto Olavi Urtti Transdermal drug delivery system
US5807570A (en) * 1995-09-29 1998-09-15 Cygnus, Inc. Transdermal administration of ropinirole and analogs thereof

Also Published As

Publication number Publication date
ATE221774T1 (de) 2002-08-15
AU3331299A (en) 1999-10-18
KR20010042173A (ko) 2001-05-25
PT1069892E (pt) 2002-12-31
EP1069892A1 (de) 2001-01-24
ES2182507T3 (es) 2003-03-01
JP2002509879A (ja) 2002-04-02
DE59902270D1 (de) 2002-09-12
EP1069892B1 (de) 2002-08-07
KR100550886B1 (ko) 2006-02-10
DE19814087A1 (de) 1999-10-14
JP4252212B2 (ja) 2009-04-08
CA2326662C (en) 2007-01-16
WO1999049853A1 (de) 1999-10-07
NO20004835L (no) 2000-09-26
US7175853B1 (en) 2007-02-13
CA2326662A1 (en) 1999-10-07
NO20004835D0 (no) 2000-09-26

Similar Documents

Publication Publication Date Title
DK1069892T3 (da) Fugtighedsaktiverbart terapeutisk system
TWI478734B (zh) 應用微囊化化學試劑延時產生一氧化氮的系統和方法
IS4083A (is) Samsetning lyfjaefna, aðferð til framleiðslu hennar, og notkunar sem lyfja
WO2002085447A8 (en) Microprojection array having a beneficial agent containing coating
DE69715049D1 (de) Tranilast enthaltendes externum und verfahren zu dessen herstellung
TR200003158T2 (tr) Jelleşebilen farmasötik bileşimler
ATE211907T1 (de) Osmotisches arzneimittelfreisetzungssystem
US4039664A (en) Topical griseofulvin composition and method
BR0210994A (pt) Compostos farmacêuticos e de diagnósticos contendo nanopartìculas úteis para tratamento de tecidos e células
BR0009771A (pt) Utilização de derivados de bisindóis indigóides capazes de penetrarem na membrana de células
PORZIO et al. EFFICACY OF A NEW TOPICAL GEL-SPRAY FORMULATION OF KETOPROFEN LYSINE SALT IN THE RAT: PERCUTANEOUS PERMEATIONIN VITROANDIN VIVOAND PHARMACOLOGICAL ACTIVITY
BR9912533A (pt) Composição farmacêutica tendo sabor melhorado
KR960021054A (ko) 위장질환 치료제용 쑥추출물
US4476115A (en) Analgesic composition and method of treating subdermal pain
TR200000249T2 (tr) Bir etki maddesinin deri üzerinden bir organizmaya geçirilmesi ve deri üzerine tatbik işlemine dair transdermal terapötik sistem (TTS)
TR200000890T2 (tr) Topik ilacın üretilmesi için -amino levülozik asidin kullanılması
JPH11302145A (ja) 日やけ止め化粧料
BR0015422A (pt) Formulações de droga de liberação prolongada
EP1297838A4 (en) PRALMORELIN-CONTAINED NOSE DROP PREPARATIONS
RU2181584C1 (ru) Стимулятор роста волос
IT1158029B (it) Preparato per ridurre traumi dei tessuti in esseri umani o animali e procedeminto per la sua produzione
UA82472C2 (uk) Трансдермальна фармацевтична композиція, що містить ацетилсаліцилову кислоту, для лікування кальцифікації
JPS643123A (en) Remedy for skin inflammation
RU2002126632A (ru) Водная лекарственная композиция для лечения заболеваний кожи
RU94022543A (ru) Основа лекарственного средства и способ ее изготовления